Model Type and Its Impact on Pneumococcal Vacci...

By João L. Carapinha

July 21, 2025

This update critically evaluates the article “Evaluating the impact of population-based and cohort-based models in cost-effectiveness analysis: a case study of pneumococcal conjugate vaccines in infants in Germany.” It explores the pneumococcal va...
DALY Modeling Methods for Enhanced Health Economics and Policy Analysis
Quantifying EU Medicine Access Challenges
Blinatumomab Benefit Assessment for ALL and Health Economics
Enhertu Reimbursement Analysis: Navigating Cost-Effectiveness Challenges
NICE HealthTech Reforms: Accelerating Digital Innovation in NHS and Global He...
Tolebrutinib MS Analysis: Evaluating Economic Impact in SPMS
NICE’s Approval of Marstacimab for Hemophilia B: Transforming Treatment...
HTA Reform Analysis: Patterns and Global Trends in Health Technology Assessment
Evolving NICE Health Technology Evaluations: Enhancing Patient Perspectives a...
Prevention Valuation: Fund Health, Not Just Savings
Implementing Health Technology Assessment in Oman
NICE Grants Conditional Robotic Surgery Approval to Enhance Patient Care and ...